25.10.2019 – 10:03Helmholtz Zentrum MünchenHelmholtz Zentrum München allies with Eli Lilly and Company to discover new targets for pancreatic beta cell regeneration in the treatment of diabetesLearn more about Helmholtz Zentrum Münchenmore
14.10.2019 – 17:27Helmholtz Zentrum MünchenDiscovery of potential novel therapeutic target for non-alcoholic fatty liver diseaseRead the papermore
12.04.2019 – 11:45Helmholtz Zentrum München2CD30 - from witness to culpritMeldung hier online lesenmore
